NIKI (NIKI) Stock Price & Analysis
NIKI (NIKI) fell 4.76% to USD 6.2 as of September 8, 2026 at 05:02 UTC, according to Nexqual real-time market data.
NIKI last closed at USD 6.2; the session ranged USD 6.05–9.68 on volume of 4,135,141 shares. Market capitalization is —, with a 52-week range of USD 6–25.9 (NCM). Source: Nexqual, September 8, 2026 at 05:02 UTC.
Key Statistics (as of September 8, 2026 at 05:02 UTC)
| Price | USD 6.2 |
|---|---|
| Change | ▼ 4.76% (down) |
| Previous Close | USD 6.2 |
| Open | USD 6.2 |
| Day Range | USD 6.05 – 9.68 |
| 52-Week Range | USD 6 – 25.9 |
| Volume | 4,135,141 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NIKI)
Nexqual's technical model rates NIKI "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:02 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.56 (oversold) |
| vs SMA50 | Below (USD 8.2) |
| MACD | -0.6 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
| ATHE | Alterity Therapeutics Limited | USD 4.54 | ▲ 0.44% |
| NMAD | Nomad Power Solutions, Inc. | USD 4.03 | ▲ 8.63% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| MEDS | DataMeds AI, Inc. | USD 0.92 | ▼ 11.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:02 UTC. This page is informational and not investment advice.